Cargando…
Tumors and Their Microenvironment Dual‐Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer
Chemotherapy turns tumor cells into “tumor vaccines” by immunogenic cell death (ICD). However, it remains a challenge to exploit chemotherapy‐induced “tumor vaccines” for solid cancer immunotherapy due to the inefficient effector T cells activation and tumor microenvironment immunosuppression. Here,...
Autores principales: | Deng, Caifeng, Zhang, Quan, Jia, Mengdi, Zhao, Jin, Sun, Xun, Gong, Tao, Zhang, Zhirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425447/ https://www.ncbi.nlm.nih.gov/pubmed/30937266 http://dx.doi.org/10.1002/advs.201801868 |
Ejemplares similares
-
Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8(+) T Cell Responses
por: Jiang, Hao, et al.
Publicado: (2017) -
Adjuvant activity of tubeimosides by mediating the local immune microenvironment
por: Han, Ziyi, et al.
Publicado: (2023) -
Penetrable Nanoplatform for “Cold” Tumor Immune Microenvironment Reeducation
por: Chen, Qinjun, et al.
Publicado: (2020) -
Tumor immune microenvironment (TIME) to enhance antitumor immunity
por: Rajbhandary, Sajin, et al.
Publicado: (2023) -
Multifunctional Nanoregulator Reshapes Immune Microenvironment and Enhances Immune Memory for Tumor Immunotherapy
por: Yu, Meng, et al.
Publicado: (2019)